Federal Register / Vol. 80, No. 56 / Tuesday, March 24, 2015 / Notices 15611 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the Sleep 

Disorders Research Advisory Board. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

Name of Committee: Sleep Disorders 

Research Advisory Board. 

Date: April 29, 2015. 

Time: 8:15 a.m. to 5:00 p.m. 

Agenda: To discuss and provide updates 

on NIH Sleep Research, the NIH Sleep 

Disorders Research Plan and inter-agency 

coordination activities, planning for. 

Place: National Institutes of Health, Fishers 

Lane Conference, Center Terrace Level, 5635 

Fisher Lane, Rockville, MD 20892. 

Contact Person: Michael J. Twery, Ph.D., 

Director, National Center on Sleep Disorders 

Research, Division of Lung Diseases, National 

Heart, Lung, and Blood Institute, National 

Institutes of Health, 6701 Rockledge Drive, 

Suite 10038, Bethesda, MD 20892–7952, 301– 

435–0199 twerym@nhlbi.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resources Research, National Institutes 

of Health, HHS) 

Dated: March 18, 2015. 

Michelle Trout, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2015–06600 Filed 3–23–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Subcommittee for Dose 

Reconstruction Reviews (SDRR), 

Advisory Board on Radiation and 

Worker Health (ABRWH or the 

Advisory Board), National Institute for 

Occupational Safety and Health 

(NIOSH) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC), 

announces the following meeting for the 

aforementioned subcommittee: 

Time and Date: 10:30 a.m.–5:00 p.m. 

EDT, April 14, 2015. 

Place: Audio Conference Call via FTS 

Conferencing. 

Status: Open to the public, but 

without a public comment period. The 

public is welcome to submit written 

comments in advance of the meeting, to 

the contact person below. Written 

comments received in advance of the 

meeting will be included in the official 

record of the meeting. The public is also 

welcome to listen to the meeting by 

joining the teleconference at the USA 

toll-free, dial-in number is 1–866–659– 

0537 and the pass code is 9933701. 

Background: The Advisory Board was 

established under the Energy Employees 

Occupational Illness Compensation 

Program Act of 2000 to advise the 

President on a variety of policy and 

technical functions required to 

implement and effectively manage the 

new compensation program. Key 

functions of the Advisory Board include 

providing advice on the development of 

probability of causation guidelines that 

have been promulgated by the 

Department of Health and Human 

Services (HHS) as a final rule; advice on 

methods of dose reconstruction, which 

have also been promulgated by HHS as 

a final rule; advice on the scientific 

validity and quality of dose estimation 

and reconstruction efforts being 

performed for purposes of the 

compensation program; and advice on 

petitions to add classes of workers to the 

Special Exposure Cohort (SEC). 

In December 2000, the President 

delegated responsibility for funding, 

staffing, and operating the Advisory 

Board to HHS, which subsequently 

delegated this authority to CDC. NIOSH 

implements this responsibility for CDC. 

The charter was issued on August 3, 

2001, renewed at appropriate intervals, 

and will expire on August 3, 2015. 

Purpose: The Advisory Board is 

charged with (a) providing advice to the 

Secretary, HHS, on the development of 

guidelines under Executive Order 

13179; (b) providing advice to the 

Secretary, HHS, on the scientific 

validity and quality of dose 

reconstruction efforts performed for this 

program; and (c) upon request by the 

Secretary, HHS, advise the Secretary on 

whether there is a class of employees at 

any Department of Energy facility who 

were exposed to radiation but for whom 

it is not feasible to estimate their 

radiation dose, and on whether there is 

reasonable likelihood that such 

radiation doses may have endangered 

the health of members of this class. The 

Subcommittee for Dose Reconstruction 

Reviews was established to aid the 

Advisory Board in carrying out its duty 

to advise the Secretary, HHS, on dose 

reconstruction. 

Matters for Discussion: The agenda for 

the Subcommittee meeting includes the 

following dose reconstruction program 

quality management and assurance 

activities: Current findings from NIOSH 

and Advisory Board dose reconstruction 

blind reviews; dose reconstruction cases 

under review including Pacific Proving 

Grounds, DuPont Deepwater Works, and 

cases from Sets 14–18, including the 

Oak Ridge sites (Y–12, K–25, Oak Ridge 

National Laboratory, and Savannah 

River Site; plans for dose reconstruction 

case reviews; preparation of the 

Advisory Board’s next report to the 

Secretary, HHS, summarizing the results 

of completed dose reconstruction 

reviews. 

The agenda is subject to change as 

priorities dictate. 

Contact Person For More Information: 

Theodore Katz, Designated Federal 

Officer, NIOSH, CDC, 1600 Clifton 

Road, Mailstop E–20, Atlanta, GA 

30333, Telephone (513) 533–6800, Toll 

Free 1 (800) CDC–INFO, Email 

ocas@cdc.gov. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2015–06643 Filed 3–23–15; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Committee to the Director 

(ACD), Centers for Disease Control and 

Prevention—Health Disparities 

Subcommittee (HDS) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following meeting of the 

aforementioned subcommittee: 

Time and Date: 10:00 a.m.–6:00 p.m. 

EDT, April 16, 2015. 

mstockstill on DSK4VPTVN1PROD with NOTICES